Results 41 to 50 of about 37,874 (304)

Treatment consensus for management of polymyositis and dermatomyositis among rheumatologists, neurologists and dermatologists

Journal of dermatology (Print), 2018
Although rheumatologists, neurologists and dermatologists see patients with polymyositis (PM) and dermatomyositis (DM), their management appears to vary depending on the physician's specialty.
H. Kohsaka, T. Mimori, T. Kanda, J. Shimizu, Y. Sunada, M. Fujimoto, Y. Kawaguchi, M. Jinnin, Y. Muro, S. Ishihara, H. Tomimitsu, Akiko Ohta, T. Sumida   +12 more
semanticscholar   +1 more source

[Polymyositis-dermatomyositis recognized during the follow-up of a patient with type 2 diabetes]. [PDF]

, 2012
Polymyositis-dermatomyositis is a rare systemic autoimmune disease which belongs to the class of idiopathic inflammatory myopathies. The disease exhibits high inter-individual variability, but chronic myositis is a common feature.
Csóka, Mária, Dankó, Katalin, Samer F,   +2 more
core   +2 more sources

Acute Exacerbation of Interstitial Lung Disease in Adult Patients With Idiopathic Inflammatory Myopathies: A Retrospective Case-Control Study

Frontiers in Medicine, 2020
Objective: This study aimed at clarifying the prevalence, risk factors, outcome, and outcome-related factors of acute exacerbation of interstitial lung disease (AE-ILD) in patients with idiopathic inflammatory myopathy (IIM).Methods: Data of IIM patients
Junyu Liang, Heng Cao, Yini Ke, Chuanyin Sun, Weiqian Chen, Jin Lin   +5 more
doaj   +1 more source

The predictive prognostic factors for polymyositis/dermatomyositis-associated interstitial lung disease

Arthritis Research & Therapy, 2018
BackgroundInterstitial lung disease (ILD) is the principal cause of death in polymyositis/dermatomyositis (PM/DM). Here we investigated prognostic factors for death and serious infection in PM/DM-ILD using the multicenter database.MethodsWe ...
Y. Sugiyama, R. Yoshimi, M. Tamura, M. Takeno, Y. Kunishita, D. Kishimoto, Y. Yoshioka, K. Kobayashi, Kaoru Takase-Minegishi, Toshiyuki Watanabe, N. Hamada, H. Nagai, N. Tsuchida, Y. Soejima, H. Nakano, R. Kamiyama, T. Uehara, Y. Kirino, A. Sekiguchi, A. Ihata, S. Ohno, S. Nagaoka, H. Nakajima   +22 more
semanticscholar   +1 more source

High-Dose Subcutaneous Immunoglobulins for the Treatment of Severe Treatment-Resistant Polymyositis

Case Reports in Rheumatology, 2014
Polymyositis is a rare debilitating condition characterized by chronic inflammation and muscle weakness. Standard treatments include corticosteroids and immunosuppressants; however, resistance to these regimens may develop.
Cherin Patrick, Delain Jean-Christophe, Crave Jean-Charles, Cartry Odile   +3 more
doaj   +1 more source

Polymyositis And Dermatomyositis - Inflammation, Muscle Structure & Immunosuppressive Treatment [PDF]

, 2012
Polymyositis and dermatomyositis are chronic, inflammatory disorders characterized by muscle weakness, low muscle endurance and by inflammation in skeletal muscle tissues.
Loell, Ingela
core   +1 more source

Myositis-specific and myositis-associated autoantibody profiles and their clinical associations in a large series of patients with polymyositis and dermatomyositis

Clinics, 2013
OBJECTIVE: To analyze the prevalence of myositis-specific and myositis-associated autoantibodies and their clinical correlations in a large series of patients with dermatomyositis/polymyositis.
Marcela Gran Pina Cruellas, Vilma dos Santos Trindade Viana, Maurício Levy-Neto, Fernando Henrique Carlos de Souza, Samuel Katsuyuki Shinjo   +4 more
doaj   +1 more source

Polimiosite : investigação clínica em duas irmãs [PDF]

, 2002
We present an investigation of a case of polymyositis affecting two sisters of one same parenthood. Their cases have been documented for almost two decades, being investigated by means of a diagnostic protocol which combined clinical findings as well as ...
Bluthner M, Bohan A, Bohan A, Bruno Rodrigues Veloso Costa, Dalakas MC, Dalakas MC, Garlepp MJ, Garlepp MJ, Ge Q, Hilário, MOE, Hokezu Y, Lewkonia RM, Margô Gomes de Oliveira Karnikowski, Matsui K, Miller FW, Miller FW, Oliveira HA, Oscar Francisco Sanchez Osella, Otávio de Tolêdo Nóbrega, Plotz PH, Rider LG, Scola RH   +21 more
core   +4 more sources

Myasthenic crisis and polymyositis induced by one dose of nivolumab

Cancer Science, 2016
An 80‐year‐old man, who developed multiple lymph node and skin metastasis of malignant melanoma, received nivolumab monotherapy. Two weeks after the first dose, he experienced anorexia and fatigue, and suffered from progressive, severe dyspnea and muscle
T. Kimura, S. Fukushima, A. Miyashita, J. Aoi, M. Jinnin, T. Kosaka, Y. Ando, M. Matsukawa, H. Inoue, K. Kiyotani, Jae-Hyun Park, Yusuke Nakamura, H. Ihn   +12 more
semanticscholar   +1 more source

Severe Rhabdomyolysis without Systemic Involvement: A Rare Case of Idiopathic Eosinophilic Polymyositis

Case Reports in Rheumatology, 2015
Introduction. Eosinophilic polymyositis (EPM) is a rare cause of rhabdomyolysis characterized by eosinophilic infiltrates in the muscle. We describe the case of a young patient with eosinophilic polymyositis causing isolated severe rhabdomyolysis without
Ayesha Farooq, Vivek Choksi, Andrew Chu, Dhruti Mankodi, Sameer Shaharyar, Keith O’Brien, Uday Shankar   +6 more
doaj   +1 more source